Francesco Parmeggiani
Citata da
Citata da
Retinitis pigmentosa: genes and disease mechanisms
S Ferrari, E Di Iorio, V Barbaro, D Ponzin, F S Sorrentino, F Parmeggiani
Current genomics 12 (4), 238-249, 2011
Mechanism of inflammation in age-related macular degeneration
F Parmeggiani, MR Romano, C Costagliola, F Semeraro, C Incorvaia, ...
Mediators of inflammation 2012, 2012
Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking
M Chizzolini, A Galan, E Milan, A Sebastiani, C Costagliola, ...
Current genomics 12 (4), 260-266, 2011
Aflibercept in wet AMD: specific role and optimal use
F Semeraro, F Morescalchi, S Duse, F Parmeggiani, E Gambicorti, ...
Drug design, development and therapy 7, 711, 2013
SSRIs and intraocular pressure modifications
C Costagliola, F Parmeggiani, A Sebastiani
CNS drugs 18 (8), 475-484, 2004
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications
C Campa, C Costagliola, C Incorvaia, C Sheridan, F Semeraro, ...
Mediators of inflammation 2010, 2010
Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure
C Costagliola, F Parmeggiani, F Semeraro, A Sebastiani
Current neuropharmacology 6 (4), 293-310, 2008
Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis
C Costagliola, A Del Prete, C Incorvaia, R Fusco, F Parmeggiani, ...
Graefe's archive for clinical and experimental ophthalmology 239 (11), 809-814, 2001
Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy
J N Sahni, M Angi, C Irigoyen, F Semeraro, M R Romano, F Parmeggiani
Current genomics 12 (4), 276-284, 2011
Editorial [Hot Topic: Clinics, Epidemiology and Genetics of Retinitis Pigmentosa (Guest Editor: Francesco Parmeggiani)]
F Parmeggiani
Current genomics 12 (4), 236-237, 2011
Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks
F Parmeggiani, FS Sorrentino, MR Romano, C Costagliola, F Semeraro, ...
Mediators of inflammation 2013, 2013
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
C Costagliola, L Agnifili, B Arcidiacono, S Duse, V Fasanella, ...
Expert opinion on biological therapy 12 (10), 1299-1313, 2012
Topical nonsteroidal anti-inflammatory drugs for macular edema
A Russo, C Costagliola, L Delcassi, F Parmeggiani, MR Romano, ...
Mediators of inflammation 2013, 2013
Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics
C Costagliola, R Dell'Omo, MR Romano, M Rinaldi, L Zeppa, ...
Expert opinion on Pharmacotherapy 10 (16), 2663-2677, 2009
Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts
G Virgili, C Pierrottet, F Parmeggiani, M Pennino, G Giacomelli, ...
Investigative ophthalmology & visual science 45 (10), 3418-3424, 2004
Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up
C Costagliola, A Del Prete, M Verolino, P Antinozzi, R Fusco, ...
Graefe's archive for clinical and experimental ophthalmology 240 (5), 379-386, 2002
Clinical and rehabilitative management of retinitis pigmentosa: up-to-date
F Parmeggiani, G Sato, K De Nadai, M R Romano, A Binotto, ...
Current genomics 12 (4), 250-259, 2011
Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age …
F Parmeggiani, C Costagliola, D Gemmati, S D'Angelo, P Perri, ...
Pharmacogenetics and genomics 17 (12), 1039-1046, 2007
Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction
FS Sorrentino, S Matteini, C Bonifazzi, A Sebastiani, F Parmeggiani
Eye 32 (7), 1157-1163, 2018
Systemic adverse drug reactions secondary to anti-VEGF intravitreal injection in patients with neovascular age-related macular degeneration
F Semeraro, F Morescalchi, F Parmeggiani, B Arcidiacono, C Costagliola
Current vascular pharmacology 9 (5), 629-646, 2011
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20